Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Irena Týcová"'
Autor:
Ondrej Viklicky, Petra Hruba, Stefan Tomiuk, Sabrina Schmitz, Bernhard Gerstmayer, Birgit Sawitzki, Patrick Miqueu, Petra Mrazova, Irena Tycova, Eva Svobodova, Eva Honsova, Uwe Janssen, Hans-Dieter Volk, Petra Reinke
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169624 (2017)
There is high medical need for safe long-term immunosuppression monotherapy in kidney transplantation. Selective targeting of post-transplant alloantigen-(re)activated effector-T cells by anti-TNF antibodies after global T cell depletion may allow sa
Externí odkaz:
https://doaj.org/article/2c4cad41cc20498d986fccedf9c14780
Autor:
Lucie Kosinová, Monika Cahová, Eva Fábryová, Irena Týcová, Tomáš Koblas, Ivan Leontovyč, František Saudek, Jan Kříž
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0152664 (2016)
The use of RT-qPCR provides a powerful tool for gene expression studies; however, the proper interpretation of the obtained data is crucially dependent on accurate normalization based on stable reference genes. Recently, strong evidence has been show
Externí odkaz:
https://doaj.org/article/094de8be66104c1e8d01e842a22810cc
Autor:
Ivan Leontovyč, Jan Kříž, Eva Fábryová, Lucie Kosinová, Monika Cahova, T. Koblas, Irena Týcová, Frantisek Saudek
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0152664 (2016)
PLoS ONE
PLoS ONE
The use of RT-qPCR provides a powerful tool for gene expression studies; however, the proper interpretation of the obtained data is crucially dependent on accurate normalization based on stable reference genes. Recently, strong evidence has been show
Autor:
Tomáš Marada, Sylvie Dusilová Sulková, Petra Hruba, Viktor Stránecký, Eva Girmanova, Ondřej Viklický, Zdeněk Krejčík, Michaela Dostalova Merkerova, Jitka Štěpánková, Marek Cernoch, Ctibor Povýšil, Květoslav Lipár, Irena Týcová
Publikováno v:
American journal of physiology. Endocrinology and metabolism. 311(4)
Secondary hyperparathyroidism is a well-known complication of end-stage renal disease (ESRD). Both nodular and diffuse parathyroid hyperplasia occur in ESRD patients. However, their distinct molecular mechanisms remain poorly understood. Parathyroid
Publikováno v:
Kidney & Blood Pressure Research, Vol 40, Iss 3, Pp 244-257 (2015)
Background/Aims: Subclinical rejection diagnosed from protocol biopsies is thought to be a risk factor of long- term allograft dysfunction. The reason why in some patients subclinical rejection does not represent risk for progression is not fully und
Externí odkaz:
https://doaj.org/article/fe60d76a527342febb6db0f10e134c79